Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Advancements in 3D Optical Imaging for Comprehensive Body Composition Assessment in Modern Research
Published on: June 7, 2024
Associations of body roundness index with cardiovascular and all-cause mortality: NHANES 2001-2018
Lin Tao1, Liu Miao1, Yu-Jie Guo1
1Departments of Cardiology, Liuzhou People's Hospital, 8 Wenchang Road, Liuzhou, 545006, Guangxi, People's Republic of China.
Insights
Body roundness index (BRI) is linked to higher cardiovascular disease (CVD) and all-cause mortality in hypertensive patients. Elevated BRI levels (>5.9 for CVD, >6.3 for all-cause) indicate increased risk, suggesting potential intervention targets.
Area of Science:
- Cardiology
- Public Health
- Biostatistics
Background:
- Body roundness index (BRI) is an emerging anthropometric indicator associated with cardiovascular diseases.
- The relationship between BRI and mortality outcomes in hypertensive individuals remains under-investigated.
Purpose of the Study:
- To investigate the association between BRI and cardiovascular disease (CVD) mortality.
- To evaluate the association between BRI and all-cause mortality in patients with hypertension.
Main Methods:
- A prospective cohort study utilizing data from the National Health and Nutrition Examination Survey (NHANES) (2001-2018).
- Included 15,570 hypertensive patients with a median follow-up of 8.0 years.
- Weighted restricted cubic spline regression and Cox proportional hazards models were employed.
Main Results:
- A nonlinear association was observed between BRI and both CVD mortality (P < 0.001) and all-cause mortality (P < 0.001).
- High BRI levels (>5.9) were associated with increased CVD mortality (HR 1.11, P < 0.001).
- High BRI levels (>6.3) were associated with increased all-cause mortality (HR 1.09, P < 0.001).
Conclusions:
- BRI demonstrates a nonlinear association with CVD and all-cause mortality in hypertensive patients.
- Specific BRI thresholds (5.9 for CVD, 6.3 for all-cause) may serve as targets for interventions to reduce premature death risk.
- Further validation in large clinical trials is warranted.
Abstract:
Body roundness index (BRI) was associated with cardiovascular diseases. But the relationship between BRI with cardiovascular disease (CVD) mortality and all-cause mortality remains largely unknown in hypertensive patients. This prospective cohort study included patients with hypertension who participated in the National Health and Nutrition Examination Survey (NHANES) from 2001 through 2018, and aimed to evaluate the association between BRI with CVD mortality and all-cause mortality. A total of 15570 patients were included. Over a median follow-up of 8.0 years (interquartile range, 4.3-12.6 years), 3445 individuals died, including 1166 CVD deaths. Weighted restricted cubic spline regression results showed a nonlinear association between BRI and CVD mortality and all-cause mortality (both P for nonlinear trend <0.001). The weighted multivariate Cox proportional hazards regression showed the hazard ratio (HRs) for CVD mortality were 0.93 (95% CI: 0.84-1.03, P = 0.160) in the low levels of BRI (≤5.9) and 1.11 (95% CI: 1.05-1.19, P < 0.001) in the high levels of BRI (>5.9). Similar associations were observed for all-cause mortality, the HRs were 0.91 (95% CI: 0.87-0.96, P < 0.001) in the low levels of BRI (≤6.3) and 1.09 (95% CI: 1.05-1.13, P < 0.001) in the high levels of BRI (>6.3). This cohort study supported that BRI was nonlinearly associated with CVD mortality and all-cause mortality among patients with hypertension. The thresholds of 5.9 and 6.3 for CVD mortality and all-cause mortality, respectively, may represent intervention targets for lowering the risk of premature death, but this needs to be confirmed in large clinical trials.
More Related Videos
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Obesity
Imaging Studies for Cardiovascular System V: CT